Gsa Capital Partners LLP Adma Biologics, Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 35,313 shares of ADMA stock, worth $713,322. This represents 0.05% of its overall portfolio holdings.

Number of Shares

35,313

Previous 144,358 75.54%

Holding current value

$713,322

Previous $1.61 Million 56.26%

% of portfolio

0.05%

Previous 0.11%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$11.21 - $20.03 $1.22 Million - $2.18 Million	-109,045 Reduced 75.54%	35,313 $706,000
Q2 2024 Aug 15, 2024	BUY	$5.98 - $11.18 $56,385 - $105,416	9,429 Added 6.99%	144,358 $1.61 Million
Q1 2024 May 03, 2024	BUY	$4.4 - $6.74 $520,146 - $796,769	118,215 Added 707.28%	134,929 $890,000
Q4 2023 Feb 16, 2024	SELL	$3.08 - $4.52 $694,755 - $1.02 Million	-225,570 Reduced 93.1%	16,714 $75,000
Q3 2023 Nov 15, 2023	BUY	$3.47 - $4.61 $392,748 - $521,778	113,184 Added 87.67%	242,284 $867,000
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $192,273 - $260,061	61,626 Added 91.33%	129,100 $476,000
Q1 2023 May 12, 2023	SELL	$3.01 - $3.87 $303,853 - $390,668	-100,948 Reduced 59.94%	67,474 $223,000
Q4 2022 Feb 13, 2023	BUY	$2.47 - $3.88 $416,002 - $653,477	168,422 New	168,422 $653,000
Q1 2022 May 11, 2022	SELL	$1.28 - $1.83 $123,619 - $176,737	-96,578 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.66 $554,438 - $844,373	-508,659 Reduced 84.04%	96,578 $136,000
Q3 2021 Nov 12, 2021	SELL	$1.13 - $1.65 $288,911 - $421,862	-255,674 Reduced 29.7%	605,237 $684,000
Q2 2021 Aug 05, 2021	BUY	$1.51 - $2.07 $470,043 - $644,364	311,287 Added 56.64%	860,911 $1.38 Million
Q1 2021 May 10, 2021	BUY	$1.67 - $2.95 $371,695 - $656,587	222,572 Added 68.05%	549,624 $967,000
Q4 2020 Feb 03, 2021	BUY	$1.8 - $2.56 $168,528 - $239,685	93,627 Added 40.11%	327,052 $638,000
Q3 2020 Nov 06, 2020	BUY	$2.04 - $3.74 $476,187 - $873,009	233,425 New	233,425 $558,000
Q2 2020 Aug 11, 2020	SELL	$2.42 - $3.29 $293,444 - $398,938	-121,258 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$1.5 - $4.59 $112,761 - $345,048	75,174 Added 163.12%	121,258 $349,000
Q4 2019 Feb 12, 2020	BUY	$3.89 - $5.15 $179,266 - $237,332	46,084 New	46,084 $184,000

Others Institutions Holding ADMA

# of Institutions

315

Shares Held

184M

Call Options Held

864K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.97B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Adma Biologics, Inc. Transaction History